Please login to the form below

Not currently logged in
Email:
Password:

market data

This page shows the latest market data news and features for those working in and with pharma, biotech and healthcare.

AZ, Merck’s Lynparza scores market-expanding clinical success

AZ, Merck’s Lynparza scores market-expanding clinical success

PARP inhibitors came to market on the strength of data showing they destroy BRCA-mutated tumours through synthetic lethality, but the phase3trial enrolled women regardless of their genetic status. ... Approval in ovarian cancer patients regardless of

Latest news

More from news
Approximately 1 fully matching, plus 125 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    Pfizer brought Ibrance to market using data from randomised controlled trials (RCTs) in women, before supplementing that evidence with real- world data (RWD) in men to expand the label. ... Ibrance gained a new approval based on data from EHRs and other

  • Global direction, local application Global direction, local application

    The best source of this data is, of course, your local market teams and agency partners, so listen and learn from them. ... 2. Just as local market variance should help define global strategy, it is essential that global strategy can be easily refined

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Centralised global or national marketing experts will focus on building core tools, market sizing and comparative metrics. ... They’ll leverage market simulation and testing to develop data-driven messaging and creative packages.

  • Brand teams: why are some smarter than others? Brand teams: why are some smarter than others?

    Compared to your rivals, you and your colleagues have similar backgrounds, use similar methods and work with more or less the same data bought from the same market research companies. ... 3.  Testing, when the hypotheses developed from the explicated

  • Market research

More from intelligence
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest appointments

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    Muhsin joins from QuintilesIMS Health, where he was therapy lead, oncology and prior to that he was a senior market analyst at Roche. ... Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical

  • LaingBuisson names chairman and CEO LaingBuisson names chairman and CEO

    Former Health Secretary Stephen Dorrell and Henry Elphick join. LaingBuisson, a UK healthcare market intelligence provider, has named Stephen Dorrell and Henry Elphick as its chairman and chief executive officer, respectively. ... Elphick said:

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S. ... market in 2017.” .

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 55 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics